Results 101 to 110 of about 3,260 (169)

Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China. [PDF]

Res Pract Thromb Haemost
Fu L, Lin X, Chen Z, Wang Z, Liu Y, Wang L, Hu Y, Ma J, Wang N, Cheng X, Ma J, Wu R.   +11 more
europepmc   +1 more source

The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation. [PDF]

Cells, 2019
Vogel JU, Schmidt S, Schmidt D, Rothweiler F, Koch B, Baer P, Rabenau H, Michel D, Stamminger T, Michaelis M, Cinatl J.   +10 more
europepmc   +1 more source

Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy. [PDF]

Hematol Rep
Salveridou K, Tzamalis T, Klaiber-Hakimi M, Haase S, Gröpper S, Giagounidis A.   +5 more
europepmc   +1 more source

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia. [PDF]

Sci Rep, 2019
Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, Revilla N, González-Porras JR, Bolaños E, Rodríguez-López MA, Orna-Montero E, Vicente V.   +20 more
europepmc   +1 more source

Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist. [PDF]

J Cell Mol Med, 2018
Xie C, Zhao H, Bao X, Fu H, Lou L.
europepmc   +1 more source

Thrombopoietin Receptor Agonists for the treatment of ITP.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources

Thrombopoietin receptor agonists for the treatment of inherited thrombocytopenia

Haematologica, 2020
openaire   +5 more sources

Phenotype description and response to thrombopoietin receptor agonist in <i>DIAPH1</i>-related disorder. [PDF]

Blood Adv, 2018
Westbury SK, Downes K, Burney C, Lozano ML, Obaji SG, Toh CH, Sevivas T, Morgan NV, Erber WN, Kempster C, Moore SF, Thys C, Papadia S, Ouwehand WH, NIHR BioResource–Rare Diseases, Laffan MA, Gomez K, Freson K, Rivera J, Mumford AD.   +19 more
europepmc   +1 more source

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report. [PDF]

Surg Case Rep, 2019
Hoshino K, Harimoto N, Muranushi R, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Yokobori T, Shirabe K.   +13 more
europepmc   +1 more source

Thrombopoietin Receptor Agonist LGD-4665 [PDF]

, 2020
openaire   +1 more source